Glaxosmithkline Pharmaceuticals Share Price
2951.90+14.40 (+0.49%)
+6.30% past 1 Year
News
GSK Pharma aims to double revenue to Rs 8,000 crores by FY30
Equity
GLAXO
Glaxosmithkline Pharmaceuticals re-appoints Bhushan Akshikar as Managing Director
Equity
GLAXO
Glaxosmithkline Pharmaceuticals Q1 EBITDA rises with stable margin performance
Equity
GLAXO
Glaxosmithkline Pharmaceuticals reports higher Q1 revenue on a year on year basis
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals posts higher Q1 consolidated net profit
Equity
GLAXO
Glaxosmithkline Pharmaceuticals faces NPPA demand notice for alleged overcharging
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals informs about letter for weblink for annual report
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals informs about secretarial compliance report
Equity
GLAXO
Glaxosmithkline Phar - Quaterly Results
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals Recommends Dividend of Rs 57 Per Share
Equity
GLAXO
GlaxoSmithKline Pharma Reports Q4 EBITDA Growth to Rs 351 Cr, Margin at 35.26% YoY
Equity
GLAXO
Glaxosmithkline Pharma Q4 Revenue Growth Beats YoY Estimates
Equity
GLAXO
Glaxosmithkline Pharma Q4 Net Profit Growth at 6.46% YoY
Equity
GLAXO
Glaxosmithkline Phar reports Profit after tax of 274.94 Crores, in the March 2026 quarter
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals informs about disclosure
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals informs about change in senior managerial personnel
Equity
GLAXO
Juby Chandy Resigns as Whole-Time Director and CFO of GSK Pharmaceuticals
Broader Market
GLAXO
GlaxoSmithKline Pharmaceuticals informs about updates
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals informs about outcome of board meeting
Equity
GLAXO
GlaxoSmithKline Pharmaceuticals informs about disclosure
Equity
GLAXO